Crystal structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group IIPAKs

被引:96
作者
Eswaran, Jeyanthy [1 ]
Lee, Wen Hwa
Debreczeni, Judit E.
Filippakopoulos, Panagis
Turnbull, Andrew
Fedorov, Oleg
Deacon, Sean W.
Peterson, Jeffrey R.
Knapp, Stefan
机构
[1] Univ Oxford, Struct Genom Consortium, Botnar Res CTr, Oxford OX3 7LD, England
[2] Fox Chase Canc Ctr, Tumor Cell Biol, Philadelphia, PA 19111 USA
基金
英国惠康基金;
关键词
D O I
10.1016/j.str.2007.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p21-activated kinases have been classified into two groups based on their domain architecture. Group II PAKs (PAK4-6) regulate a wide variety of cellular functions, and PAK deregulation has been linked to tumor development. Structural comparison of five high-resolution structures comprising all active, monophosphorylated group II catalytic domains revealed a surprising degree of domain plasticity, including a number of catalytically productive and nonproductive conformers. Rearrangements of helix alpha C, a key regulatory element of kinase function, resulted in an additional helical turn at the alpha C N terminus and a distortion of its C terminus, a movement hitherto unseen in protein kinases. The observed structural changes led to the formation of interactions between conserved residues that structurally link the glycine-rich loop, aC, and the activation segment and firmly anchor aC in an active conformation. Inhibitor screening identified six potent PAK inhibitors from which a tri-substituted purine inhibitor was cocrystallized with PAK4 and PAK5.
引用
收藏
页码:201 / 213
页数:13
相关论文
共 63 条
[11]   p21-activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD [J].
Cotteret, S ;
Jaffer, ZM ;
Beeser, A ;
Chernoff, J .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (16) :5526-5539
[12]   Induction of Apoptosis in Human Leukemia Cells by the CDK1 Inhibitor CGP74514A [J].
Dai, Yun ;
Dent, Paul ;
Grant, Steven .
CELL CYCLE, 2002, 1 (02) :143-152
[13]   Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds [J].
Dalgarno, D ;
Stehle, T ;
Narula, S ;
Schelling, P ;
van Schravendijk, MR ;
Adams, S ;
Andrade, L ;
Keats, J ;
Ram, M ;
Jin, L ;
Grossman, T ;
MacNeil, I ;
Metcalf, C ;
Shakespeare, W ;
Wang, Y ;
Keenan, T ;
Sundaramoorthi, R ;
Bohacek, R ;
Weigele, M ;
Sawyer, T .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (01) :46-57
[14]   Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin [J].
Dan, C ;
Kelly, A ;
Bernard, O ;
Minden, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :32115-32121
[15]   Rac/Cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin through phosphorylation at serine 16 [J].
Daub, H ;
Gevaert, K ;
Vandekerckhove, J ;
Sobel, A ;
Hall, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (03) :1677-1680
[16]   Localization of p21-activated kinase 1 (PAK1) to pinocytic vesicles and cortical actin structures in stimulated cells [J].
Dharmawardhane, S ;
Sanders, LC ;
Martin, SS ;
Daniels, RH ;
Bokoch, GM .
JOURNAL OF CELL BIOLOGY, 1997, 138 (06) :1265-1278
[17]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[18]  
EVANS PR, 1993, P CCP4 STUD WEEK DAT, P114
[19]   In vitro evaluation of a novel 2,6,9-trisubstituted purine acting as a cyclin-dependent kinase inhibitor [J].
Giocanti, N ;
Sadri, R ;
Legraverend, M ;
Ludwig, O ;
Bisagni, E ;
Leclerc, S ;
Meijer, L ;
Favaudon, V .
ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 :180-182
[20]   Structure of the complex of Cdc42Hs with a peptide derived from p-21 activated kinase [J].
Gizachew, D ;
Guo, W ;
Chohan, KK ;
Sutcliffe, MJ ;
Oswald, RE .
BIOCHEMISTRY, 2000, 39 (14) :3963-3971